Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kaletra”

Showing 9 of 0 results

Post-approval studies (Phase 4)Study completedNCT00756730
What this trial is testing

Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r

Who this might be right for
HIV Infections
Community Research Initiative of New England 49
Not applicableStudy completedNCT04425382
What this trial is testing

Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar

Who this might be right for
CoronavirusCOVIDPneumonia
Hamad Medical Corporation 400
Not applicableStudy completedNCT00200369
What this trial is testing

Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-based Regimen

Who this might be right for
HIV Infection
Montefiore Medical Center 90
Large-scale testing (Phase 3)Study completedNCT00038519
What this trial is testing

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

Who this might be right for
HIV Infections
Abbott 16
Post-approval studies (Phase 4)Study completedNCT00244712
What this trial is testing

Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV

Who this might be right for
HIV Infection
GlaxoSmithKline 688
Early research (Phase 1)Study completedNCT00867152
What this trial is testing

GSK1349572 Drug Interaction With Etravirine and Either Darunavir/Ritonavir or Lopinavir/Ritonavir

Who this might be right for
Healthy Volunteer
ViiV Healthcare 17
Large-scale testing (Phase 3)Study completedNCT01172535
What this trial is testing

A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 97
Not applicableEnded earlyNCT04138199
What this trial is testing

Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian Federation

Who this might be right for
HIV-1 Infection
AbbVie 239
Not applicableStudy completedNCT01662336
What this trial is testing

Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program

Who this might be right for
Human Immunodeficiency Virus Infection
AbbVie (prior sponsor, Abbott) 173

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation